Abstract
Objective
To compare the efficacy of Autologous Platelet-Rich Fibrin (PRF) versus Normal Saline (NS) dressings in healing Chronic Venous Leg Ulcers (CVLUs), focusing on ulcer area reduction and quality of life.
Methods
A randomized controlled trial was conducted at a tertiary care center involving 74 patients with chronic venous leg ulcers (CVLUs). Patients were randomized into two groups: Group A (n = 36) received autologous platelet-rich fibrin (PRF) dressings with four-layer compression therapy, while Group B (n = 38) received Normal Saline (NS) dressings with four-layer compression therapy. Ulcer area and Quality of Life were assessed at baseline and at predefined intervals up to 4 weeks, with continued follow-up for 6 months. The quality of life was assessed using the Charing Cross Venous Ulcer Questionnaire (CCVUQ) and the EuroQol-5 Dimension-5 Level (EQ-5D-5L) scores.
Results
Both groups showed a reduction in ulcer area over time. In the PRF group, mean ulcer area decreased significantly from baseline to 4 weeks (17.46 ± 11.52 cm2 to 9.92 ± 8.73 cm2; p = 0.007), whereas the reduction in the saline group was not statistically significant (14.07 ± 14.43 cm2 to 11.45 ± 12.02 cm2; p = 0.913). Between-group comparison at 4 weeks was not significant; however, from 4 weeks onward, the PRF group consistently demonstrated smaller mean ulcer areas, with the greatest difference observed at 6 months. CCVUQ and EQ-5D-5L scores improved over time in both groups, with a transient between-group difference favoring PRF at 4 weeks for CCVUQ but no sustained head-to-head superiority in quality-of-life outcomes.
Conclusion
Autologous PRF, when used as an adjunct to standard compression therapy, is associated with earlier and sustained reduction in ulcer area and improvement in ulcer-related Quality-of-Life in patients with chronic venous leg ulcers. No treatment related adverse events were observed during the study period.
Get full access to this article
View all access options for this article.